These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18522771)

  • 1. Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone.
    Fujimoto H; Tao S; Dohi T; Ito S; Masuda J; Haruo M; Fujimoto Y; Maehara A; Yamaguchi T; Ishiwata S; Ohno M
    J Cardiol; 2008 Feb; 51(1):18-24. PubMed ID: 18522771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial.
    Alfonso F; Pérez-Vizcayno MJ; Hernandez R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Mantilla R; Morís C; Cequier A; Sabaté M; Escaned J; Moreno R; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2152-60. PubMed ID: 16750678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents.
    Sousa JE; Costa MA; Abizaid A; Feres F; Seixas AC; Tanajura LF; Mattos LA; Falotico R; Jaeger J; Popma JJ; Serruys PW; Sousa AG
    Circulation; 2005 May; 111(18):2326-9. PubMed ID: 15851603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
    J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A
    Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sirolimus-eluting stent on calcified coronary lesions.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2008 Jan; 121(1):6-11. PubMed ID: 18208656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry).
    Roy P; Bonello L; de Labriolle A; Okabe T; Pinto Slottow TL; Steinberg DH; Torguson R; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2008 Aug; 102(3):292-7. PubMed ID: 18638589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISR II study: a long-term evaluation of sirolimus-eluting stent in the treatment of patients with in-stent restenotic native coronary artery lesions.
    Commeau P; Barragan PT; Roquebert PO; Siméoni JB
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):158-62. PubMed ID: 16158397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design: impact of intravascular ultrasound guidance on long-term clinical outcomes of everolimus-eluting stents in long coronary lesions.
    Cho S; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Contemp Clin Trials; 2015 Jan; 40():90-4. PubMed ID: 25433202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-stent pseudo-restenosis due to an organized thrombus six months after implantation of a sirolimus-eluting stent.
    Murasato Y; Okamatsu K
    J Invasive Cardiol; 2007 Mar; 19(3):145-8. PubMed ID: 17341784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of Chinese made sirolimus eluting stents: results, including off label usage, from two centres over three years.
    Zhang Q; Xu B; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Chen JL; Shen WF; Gao RL
    Chin Med J (Engl); 2008 Sep; 121(17):1670-4. PubMed ID: 19024097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow up of diabetic patients treated with sirolimus-eluting stents. An angiographic and three-dimensional intravascular ultrasound study.
    Vaz VD; Abizaid A; Chaves A; Feres F; Ferreira E; Mattos L; Staico R; Abizaid A; Tanajura L; Centemero M; Mintz G; Sousa A; Sousa JE
    J Invasive Cardiol; 2006 Apr; 18(4):142-6. PubMed ID: 16729398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application, feasibility, and efficacy of a combined intravascular ultrasound and stent delivery system: results from a prospective multicenter trial.
    Rieber J; Gockel K; Koschyk D; Erhard I; Koenig A; Schiele TM; Theisen K; Siebert U; Klauss V
    J Interv Cardiol; 2005 Oct; 18(5):367-74. PubMed ID: 16202113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of metabolic syndrome on clinical and angiographic outcome after sirolimus-eluting stent implantation.
    Stellbrink E; Schröder J; Grawe A; Goebbels R; Blindt R; Kelm M; Hoffmann R
    Coron Artery Dis; 2007 Dec; 18(8):601-6. PubMed ID: 18004109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study).
    Rahel BM; Laarman GJ; Kelder JC; Ten Berg JM; Suttorp MJ
    Am Heart J; 2009 Jan; 157(1):149-55. PubMed ID: 19081412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.